๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Biomarkers in early breast neoplasia

โœ Scribed by D. Craig Allred; Peter O'Connell; Suzanne A. W. Fuqua

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
578 KB
Volume
53
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

โœฆ Synopsis

Early breast neoplasia may be defined in many ways. Any non-invasive or invasive but nonmetastatic breast cancer qualifies as early neoplasia in the sense that they are non-lethal. Before we can prevent lethal breast cancer, we must gain a better understanding of the biological abnormalities underlying its development and progression. Many studies into the mechanisms of breast cancer evolution have evaluated potential precursor lesions kg., proliferative disease without atypia [PDWA],

๐Ÿ“œ SIMILAR VOLUMES

Genetic surrogate endpoint biomarkers in
Genetic surrogate endpoint biomarkers in early breast neoplasia
โœ D. Craig Allred ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB

## Genetic Surrogate Endpoint Biomarkers in Early Breast Neoplasia "Biomarkers in Early Breast Neoplasia," presented by D. Craig Allred. The biological mechanisms of breast cancer evolution are poorly understood. Furthermore, this problem has been difficult to study because potential precursor les

Genetic surrogate endpoint biomarkers in
Genetic surrogate endpoint biomarkers in early breast neoplasia
โœ Leslie Brand ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 62 KB

Carolina) discussed the relationship of oncogenes and breast cancer. Specifically, he described much of the recent work with HER-2/neu, PRADI, and p53. Some of these genetic lesions appear early in the breast cancer process and are stable as the tumors become invasive and metastasize. Dr. Liu also p

Antigenic changes in human breast neopla
Antigenic changes in human breast neoplasia
โœ Eugene M. Edynak; Michael P. Lardis; Mark Vrana ๐Ÿ“‚ Article ๐Ÿ“… 1971 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 654 KB
Altered expression of transforming growt
Altered expression of transforming growth factor-ฮฒ1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix
โœ John T. Comerci Jr.; Carolyn D. Runowicz; Kathleen C. Flanders; Carol De Victori ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 986 KB

Transforming growth factor-Pl (TGF-Pl) is a potent growth inhibitor of epithelial cell growth, but can also stimulate stromal cell growth. Loss of responsiveness to TGF-/)l or loss of TGF-P1 itself may be important in the progression of cervical intraepithelial neoplasia (CIN) to invasive cervical c